Oral HRT accepted for use across Scotland while availability remains limited in England Bijuve has been been approved for use across Scotland, but it is only available in some local formularies in England, owing to backlogs caused by COVID-19.…
Cannabis-based Sativex approved for NHS use in Scotland The Scottish Medicines Consortium's decision to approve Sativex brings it in line with the rest of the UK.…
Siponimod now recommended for patients with secondary progressive MS Updated draft guidance from the National Institute for Health and Care Excellence has recommended siponimod for the treatment of secondary progressive multiple sclerosis.…
Scottish Medicines Consortium accepts nasal spray for depression previously rejected by NICE The Scottish Medicines Consortium has accepted the use of esketamine nasal spray for use within NHS Scotland for adults with treatment-resistant major depressive disorder.…
Cannabis-based Epidyolex approved for NHS use in Scotland Epidyolex, a cannabidiol medicine for severe epilepsy in children, has been approved for use on the NHS in Scotland.…
Biologic injection for severe asthma approved in Scotland A biologic injection intended for the treatment of severe eosinophilic asthma has been accepted for restricted use by the Scottish Medicines Consortium, providing another option for patients who fail to respond to other treatments.…
Daratumumab recommended for treatment of multiple myeloma in Scotland The Scottish Medicines Consortium (SMC) has recommended daratumumab (Darzalex) for use as a fourth-line treatment option in multiple myeloma.…
Scotland will fund pre-exposure prophylaxis for people at high risk of HIV People in Scotland at risk of HIV will be able to access pre-exposure prophylaxis (PrEP) treatment on the NHS.…
Breast cancer drug deemed too expensive in England has been approved in Scotland NHS Scotland has approved the use of breast cancer drug Kadcyla, which was rejected for use in England on the grounds that its benefits did not justify its cost.…
Cancer charities say patients are being denied access to new drugs NHS cancer patients are missing out on innovative new drugs which are available in other European countries because of a flawed assessment and pricing system, according to a report published by cancer charities Breast Cancer Now and Prostate Cancer UK.…
